ArticleCell death & disease2024

PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer.

Jing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.